The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion

Abstract Background In-transit metastasis is considered a locoregional disease in cutaneous melanoma (CM) patients. Isolated limb perfusion (ILP) is among the treatment options in selected cases. The aim of this study was to determine the success of pre- and post-perfusion mSIS values in predicting...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Şevket Barış Morkavuk, Serdar Çulcu, Ebru Esen, Ali Ekrem Ünal
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/656a8ca3a57d4609ba724936b430b2ba
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:656a8ca3a57d4609ba724936b430b2ba
record_format dspace
spelling oai:doaj.org-article:656a8ca3a57d4609ba724936b430b2ba2021-11-21T12:33:38ZThe diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion10.1186/s12957-021-02437-61477-7819https://doaj.org/article/656a8ca3a57d4609ba724936b430b2ba2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12957-021-02437-6https://doaj.org/toc/1477-7819Abstract Background In-transit metastasis is considered a locoregional disease in cutaneous melanoma (CM) patients. Isolated limb perfusion (ILP) is among the treatment options in selected cases. The aim of this study was to determine the success of pre- and post-perfusion mSIS values in predicting the potential complications and the prognosis of the disease by investigating the early and long-term results of mSIS values calculated before and after ILP in CM cases with in-transit metastases. Materials and methods Patients who underwent ILP within the period from 2014 to 2020 in our department were retrospectively scanned. A total of 20 patients were found to undergo ILP. The scores obtained from modified inflammation score (mSIS) were formulated according to albumin (Alb) and lymphocyte to monocyte ratio (LMR) scores. Results The mean follow-up time was 20.47 months. Complications requiring surgical intervention developed in three patients. According to the Wieberdink local toxicity classification, the majority (70%) of the patients were found to be grade II. Based on pre-perfusion mSIS values, 8 patients were classified as mSIS 0 while six patients were classified as mSIS 1 and 2. Based on post-perfusion mSIS values, 14 patients and one patient were classified as mSIS 2 (70%) and mSIS 0, respectively. Accordingly, univariate analysis showed that mSIS 1 and mSIS 2 were negative prognostic factors for mean survival in the pre-perfusion period (HR 0.162, 95% CI 0.036–0.729; p = 0.018 and HR: 0.223, 95% CI 0.049–1.019; p = 0.053) whereas albumin (Alb) and lymphocyte to monocyte ratio (LMR) were not independent prognostic factors for mean survival. Conclusion The mSIS values calculated in the pre-perfusion period can give an opinion about the OS of the patients whereas post-perfusion mSIS values may predict potential surgical complications and local toxicities.Şevket Barış MorkavukSerdar ÇulcuEbru EsenAli Ekrem ÜnalBMCarticleIsolated limb perfusionModified systemic inflammation scoreCutaneous melanomaLymphocyte-to-monocyte ratioAlbuminSurgeryRD1-811Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENWorld Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Isolated limb perfusion
Modified systemic inflammation score
Cutaneous melanoma
Lymphocyte-to-monocyte ratio
Albumin
Surgery
RD1-811
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Isolated limb perfusion
Modified systemic inflammation score
Cutaneous melanoma
Lymphocyte-to-monocyte ratio
Albumin
Surgery
RD1-811
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Şevket Barış Morkavuk
Serdar Çulcu
Ebru Esen
Ali Ekrem Ünal
The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
description Abstract Background In-transit metastasis is considered a locoregional disease in cutaneous melanoma (CM) patients. Isolated limb perfusion (ILP) is among the treatment options in selected cases. The aim of this study was to determine the success of pre- and post-perfusion mSIS values in predicting the potential complications and the prognosis of the disease by investigating the early and long-term results of mSIS values calculated before and after ILP in CM cases with in-transit metastases. Materials and methods Patients who underwent ILP within the period from 2014 to 2020 in our department were retrospectively scanned. A total of 20 patients were found to undergo ILP. The scores obtained from modified inflammation score (mSIS) were formulated according to albumin (Alb) and lymphocyte to monocyte ratio (LMR) scores. Results The mean follow-up time was 20.47 months. Complications requiring surgical intervention developed in three patients. According to the Wieberdink local toxicity classification, the majority (70%) of the patients were found to be grade II. Based on pre-perfusion mSIS values, 8 patients were classified as mSIS 0 while six patients were classified as mSIS 1 and 2. Based on post-perfusion mSIS values, 14 patients and one patient were classified as mSIS 2 (70%) and mSIS 0, respectively. Accordingly, univariate analysis showed that mSIS 1 and mSIS 2 were negative prognostic factors for mean survival in the pre-perfusion period (HR 0.162, 95% CI 0.036–0.729; p = 0.018 and HR: 0.223, 95% CI 0.049–1.019; p = 0.053) whereas albumin (Alb) and lymphocyte to monocyte ratio (LMR) were not independent prognostic factors for mean survival. Conclusion The mSIS values calculated in the pre-perfusion period can give an opinion about the OS of the patients whereas post-perfusion mSIS values may predict potential surgical complications and local toxicities.
format article
author Şevket Barış Morkavuk
Serdar Çulcu
Ebru Esen
Ali Ekrem Ünal
author_facet Şevket Barış Morkavuk
Serdar Çulcu
Ebru Esen
Ali Ekrem Ünal
author_sort Şevket Barış Morkavuk
title The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
title_short The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
title_full The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
title_fullStr The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
title_full_unstemmed The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
title_sort diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
publisher BMC
publishDate 2021
url https://doaj.org/article/656a8ca3a57d4609ba724936b430b2ba
work_keys_str_mv AT sevketbarısmorkavuk thediagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
AT serdarculcu thediagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
AT ebruesen thediagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
AT aliekremunal thediagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
AT sevketbarısmorkavuk diagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
AT serdarculcu diagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
AT ebruesen diagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
AT aliekremunal diagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
_version_ 1718418947591634944